[FG] Gensicke Henrik

Filioglo, Andrei et al. (2024) ‘Corrigendum: Tandem occlusions involving the internal carotid and anterior cerebral arteries—A rare form of stroke: results from the multicenter EVATRISP collaboration study (Frontiers in Neurology, (2022), 13, (1024891), 10.3389/fneur.2022.1024891)’, Frontiers in Neurology, 15. Available at: https://doi.org/10.3389/fneur.2024.1450372.

Kaufmann, Josefin E. et al. (2024) ‘Toward Individual Treatment in Cervical Artery Dissection: Subgroup Analysis of the TREAT-CAD Randomized Trial’, Annals of Neurology [Preprint]. Available at: https://doi.org/10.1002/ana.26886.

Kaufmann, Josefin E. et al. (2024) ‘Antithrombotic Treatment for Cervical Artery Dissection: A Systematic Review and Individual Patient Data Meta-Analysis’, JAMA Neurology, 81, pp. 630–637. Available at: https://doi.org/10.1001/jamaneurol.2024.1141.

Wali, Nabila et al. (2024) ‘Endovascular treatment in patients with acute ischemic stroke presenting beyond 6 h after symptom onset: An international multicenter cohort study of the EVA-TRISP collaboration’, European Stroke Journal [Preprint]. Available at: https://doi.org/10.1177/23969873241277437.

Seystahl K et al. (2023) ‘IV Thrombolysis With or Without Endovascular Treatment for Suspected Ischemic Stroke in Patients With Intracranial Tumors.’, Neurology, 101(12), pp. e1241–e1255. Available at: https://doi.org/10.1212/wnl.0000000000207624.

Altersberger, Valerian L. et al. (2023) ‘Intravenous Thrombolysis 4.5–9 Hours After Stroke Onset: A Cohort Study from the TRISP Collaboration’, Annals of Neurology, 94(2), pp. 309–320. Available at: https://doi.org/10.1002/ana.26669.

Baumgartner P et al. (2023) ‘Safety and effectiveness of IV Thrombolysis in retinal artery occlusion: A multicenter retrospective cohort study.’, European stroke journal, p. 23969873231185895. Available at: https://doi.org/10.1177/23969873231185895.

Al-Ajlan FS et al. (2023) ‘Time Course of Early Hematoma Expansion in Acute Spot-Sign Positive Intracerebral Hemorrhage: Prespecified Analysis of the SPOTLIGHT Randomized Clinical Trial.’, Stroke, 54(3), pp. 715–721. Available at: https://doi.org/10.1161/strokeaha.121.038475.

Bakker, M.K. et al. (2023) ‘Genetic Risk Score for Intracranial Aneurysms: Prediction of Subarachnoid Hemorrhage and Role in Clinical Heterogeneity’, Stroke, 54(3), pp. 810–818. Available at: https://doi.org/10.1161/strokeaha.122.040715.

Marto JP et al. (2023) ‘Safety and Outcome of Revascularization Treatment in Patients With Acute Ischemic Stroke and COVID-19: The Global COVID-19 Stroke Registry.’, Neurology, 100(7), pp. e739–e750. Available at: https://doi.org/10.1212/wnl.0000000000201537.

Alexander Salerno et al. (2023) ‘BEST REVASCULARIZATION APPROACH FOR POSTERIOR CIRCULATION STROKES WITH ISOLATED VERTEBRAL ARTERY OCCLUSIONS: RESULTS FROM THE “BRAVO” RETROSPECTIVE STUDY ’, in European Stroke Organisation Conference . Munich, Germany (European Stroke Organisation Conference ).

Alexandros Polymeris et al. (2023) ‘OUTCOMES OF ATRIAL FIBRILLATION KNOWN BEFORE OR DETECTED AFTER ISCHEMIC STROKE: ROLE OF ANTICOAGULATION’, in European Stroke Organisation Conference. Munich, Germany (European Stroke Organisation Conference).

Altersberger, Valerian L. et al. (2023) ‘Intravenous Thrombolysis 4.5–9 Hours After Stroke Onset: A Cohort Study from the TRISP Collaboration’, Annals of Neurology. 28.04.2023, 94(2), pp. 309–320. Available at: https://doi.org/10.1002/ana.26669.

Dittrich, Tolga D et al. (2023) ‘Apical pulmonary lesions suspected of malignancy visible on neck CT angiography performed for acute stroke: Prevalence, treatment, and clinical implications – the PLEURA study’, European Stroke Journal, 8, pp. 549–556. Available at: https://doi.org/10.1177/23969873231151488.

Dittrich, Tolga D et al. (2023) ‘Mechanical thrombectomy for large vessel occlusion between 6 and 24 h: outcome comparison of DEFUSE-3/DAWN eligible versus non-eligible patients’, International Journal of Stroke, 18, pp. 697–703. Available at: https://doi.org/10.1177/17474930221140793.

Dittrich, Tolga D. et al. (2023) ‘Mechanical Thrombectomy Versus Best Medical Treatment in the Late Time Window in Non-DEFUSE-Non-DAWN Patients: A Multicenter Cohort Study’, Stroke, 54, pp. 722–730. Available at: https://doi.org/10.1161/strokeaha.122.039793.

Enz, Lukas Simon et al. (2023) ‘An Animal Model for Chronic Meningeal Inflammation and Inflammatory Demyelination of the Cerebral Cortex’, International Journal of Molecular Sciences, 24(18), p. 13893. Available at: https://doi.org/10.3390/ijms241813893.

JE Kaufmann et al. (2023) ‘Towards Individual Treatment in Cervical Artery Dissection—An In‑Depth Analysis of the TREAT‑CAD Randomised Trial’, in Annual Meeting of the Swiss Neurological Society and Swiss Society of Neurosurgery. Zurich (Annual Meeting of the Swiss Neurological Society and Swiss Society of Neurosurgery).

Josefin E. Kaufmann et al. (2023) ‘TOWARDS INDIVIDUAL TREATMENT IN CERVICAL ARTERY DISSECTION - AN INDEPTH ANALYSIS OF THE TREAT-CAD RANDOMISED TRIAL’, in European Stroke Organisation Conference. Munich, Germany (European Stroke Organisation Conference).

K. Seystahl et al. (2023) ‘ INTRAVENOUS THROMBOLYSIS WITH OR WITHOUT ENDOVASCULAR TREATMENT FOR SUSPECTED ISCHEMIC STROKE IN PATIENTS WITH INTRACRANIAL TUMORS’, in 18th Meeting of the European Association of Neuro-Oncology. Rotterdam, Netherlands (18th Meeting of the European Association of Neuro-Oncology).

Lyrer, Flurina et al. (2023) ‘Atrial Fibrillation Detected before or after Stroke: Role of Anticoagulation’, Annals of Neurology, 94, pp. 43–54. Available at: https://doi.org/10.1002/ana.26654.

Meinel, Thomas R. et al. (2023) ‘Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral Anticoagulants’, JAMA Neurology, 80, pp. 233–243. Available at: https://doi.org/10.1001/jamaneurol.2022.4782.

Tolga Dittrich et al. (2023) ‘APICAL PULMONARY LESIONS SUSPECTED OF MALIGNANCY VISIBLE ON NECK CT ANGIOGRAPHY PERFORMED FOR ACUTE STROKE: PREVALENCE, REATMENT AND CLINICAL IMPLICATIONS – THE PLEURA STUDY’, in European Stroke Organisation Conference. Munich, Germany (European Stroke Organisation Conference).

Traenka, Christopher et al. (2023) ‘Recanalization Therapies for Large Vessel Occlusion Due to Cervical Artery Dissection: A Cohort Study of the EVA-TRISP Collaboration’, Journal of Stroke, 25, pp. 272–281. Available at: https://doi.org/10.5853/jos.2022.03370.

Sztajzel RF et al. (2022) ‘Carotid plaque surface echogenicity predicts cerebrovascular events: An Echographic Multicentric Swiss Study.’, Journal of neuroimaging : official journal of the American Society of Neuroimaging, 32(6), pp. 1142–1152. Available at: https://doi.org/10.1111/jon.13026.

Altersberger VL et al. (2022) ‘Thrombolysis in stroke patients with elevated inflammatory markers.’, Journal of neurology, 269(10), pp. 5405–5419. Available at: https://doi.org/10.1007/s00415-022-11173-0.

Duman M et al. (2022) ‘Theophylline Induces Remyelination and Functional Recovery in a Mouse Model of Peripheral Neuropathy.’, Biomedicines, 10(6). Available at: https://doi.org/10.3390/biomedicines10061418.

Altersberger VL et al. (2022) ‘Effect of admission time on provision of acute stroke treatment at stroke units and stroke centers-An analysis of the Swiss Stroke Registry.’, European stroke journal, 7(2), pp. 117–125. Available at: https://doi.org/10.1177/23969873221094408.

De Marchis GM et al. (2022) ‘Association of the COVID-19 outbreak with acute stroke care in Switzerland.’, European journal of neurology, 29(3), pp. 724–731. Available at: https://doi.org/10.1111/ene.15209.

Fladt J et al. (2022) ‘Acute stroke imaging selection for mechanical thrombectomy in the extended time window: is it time to go back to basics? A review of current evidence.’, Journal of neurology, neurosurgery, and psychiatry, 93(3), pp. 238–245. Available at: https://doi.org/10.1136/jnnp-2021-328000.

Potasso L et al. (2022) ‘Impact of Sodium Levels on Functional Outcomes in Patients With Stroke - A Swiss Stroke Registry Analysis.’, The Journal of clinical endocrinology and metabolism, 107(2), pp. e672–e680. Available at: https://doi.org/10.1210/clinem/dgab650.

Filioglo A et al. (2022) ‘Outcomes after reperfusion therapies in patients with ACA stroke: A multicenter cohort study from the EVATRISP collaboration.’, Journal of the neurological sciences, 432, p. 120081. Available at: https://doi.org/10.1016/j.jns.2021.120081.

Schaub F et al. (2022) ‘Differences Between Anticoagulated Patients With Ischemic Stroke Versus Intracerebral Hemorrhage.’, Journal of the American Heart Association, 11(1), p. e023345. Available at: https://doi.org/10.1161/jaha.121.023345.

Altersberger, Valerian L. et al. (2022) ‘Intravenous Thrombolysis in Patients With Ischemic Stroke Aged ≥90 Years: A Cohort Study From the TRISP Collaboration’, Stroke, 53, pp. 3557–3563. Available at: https://doi.org/10.1161/strokeaha.122.039426.

Filioglo A et al. (2022) ‘Tandem occlusions involving the internal carotid and anterior cerebral arteries-A rare form of stroke: Results from the multicenter EVATRISP collaboration study.’, Frontiers in neurology, 13, p. 1024891. Available at: https://doi.org/10.3389/fneur.2022.1024891.

Qazi S. et al. (2021) ‘Identifying thrombus on non-contrast CT in patients with acute ischemic stroke’, Diagnostics, 11(10). Available at: https://doi.org/10.3390/diagnostics11101919.

Halliday A. et al. (2021) ‘Second asymptomatic carotid surgery trial (ACST-2): a randomised comparison of carotid artery stenting versus carotid endarterectomy.’, Lancet (London, England), 398(10305), pp. 1065–1073. Available at: https://doi.org/10.1016/s0140-6736(21)01910-3.

Nordanstig A et al. (2021) ‘EndoVAscular treatment and ThRombolysis for Ischemic Stroke Patients (EVA-TRISP) registry: basis and methodology of a pan-European prospective ischaemic stroke revascularisation treatment registry.’, BMJ open, 11(8), p. e042211. Available at: https://doi.org/10.1136/bmjopen-2020-042211.

Altersberger, Valerian L. et al. (2021) ‘Maintenance of Acute Stroke Care Service During the COVID-19 Pandemic Lockdown.’, Stroke. 01.04.2021, 52(5), pp. 1693–1701. Available at: https://doi.org/10.1161/strokeaha.120.032176.

Traenka C et al. (2020) ‘Biomarkers and antithrombotic treatment in cervical artery dissection - Design of the TREAT-CAD randomised trial.’, European stroke journal, 5(3), pp. 309–319. Available at: https://doi.org/10.1177/2396987320921151.

Malhotra K et al. (2020) ‘Intravenous thrombolysis in patients with chronic kidney disease: A systematic review and meta-analysis.’, Neurology, 95(2), pp. e121–e130. Available at: https://doi.org/10.1212/wnl.0000000000009756.

Enz LS et al. (2020) ‘Increased HLA-DR expression and cortical demyelination in MS links with HLA-DR15.’, Neurology(R) neuroimmunology & neuroinflammation, 7(2). Available at: https://doi.org/10.1212/nxi.0000000000000656.

Gensicke H et al. (2020) ‘Comparison of different methods of thrombus permeability measurement and impact on recanalization in the INTERRSeCT multinational multicenter prospective cohort study.’, Neuroradiology, 62(3), pp. 301–306. Available at: https://doi.org/10.1007/s00234-019-02320-y.

Seiffge DJ et al. (2020) ‘Ischemic Stroke despite Oral Anticoagulant Therapy in Patients with Atrial Fibrillation.’, Annals of neurology, 87(5), pp. 677–87. Available at: https://doi.org/10.1002/ana.25700.

Traenka C et al. (2020) ‘Artery occlusion independently predicts unfavorable outcome in cervical artery dissection.’, Neurology, 94(2), pp. e170–e180. Available at: https://doi.org/10.1212/wnl.0000000000008654.

Altersberger, Valerian L. et al. (2020) ‘Prior Dual Antiplatelet Therapy and Thrombolysis in Acute Stroke’, Annals of Neurology. 19.07.2020, 88(4), pp. 857–859. Available at: https://doi.org/10.1002/ana.25850.

Westphal, Laura P. et al. (2020) ‘Association of prestroke metformin use, stroke severity, and thrombolysis outcome’, Neurology, 95(4), pp. e362–e373. Available at: https://doi.org/10.1212/wnl.0000000000009951.

Enz LS et al. (2019) ‘Combinatory Multifactor Treatment Effects on Primary Nanofiber Oligodendrocyte Cultures.’, Cells, 8(11). Available at: https://doi.org/10.3390/cells8111422.

Polymeris AA et al. (2019) ‘Intravenous thrombolysis for suspected ischemic stroke with seizure at onset.’, Annals of neurology, 86(5), pp. 770–779. Available at: https://doi.org/10.1002/ana.25582.

Manno C et al. (2019) ‘Outcome of endovascular therapy in stroke with large vessel occlusion and mild symptoms.’, Neurology, 93(17), pp. e1618–e1626. Available at: https://doi.org/10.1212/wnl.0000000000008362.

De Marchis, Gian Marco et al. (2019) ‘A novel biomarker-based prognostic score in acute ischemic stroke: The CoRisk score’, Neurology, 92(13), pp. e1517–e1525. Available at: https://doi.org/10.1212/wnl.0000000000007177.

Fladt, Joachim et al. (2019) ‘Reasons for prehospital delay in acute ischemic stroke’, Journal of the American Heart Association, 8(20), p. e013101. Available at: https://doi.org/10.1161/jaha.119.013101.

Zonneveld TP et al. (2018) ‘Non-office-hours admission affects intravenous thrombolysis treatment times and clinical outcome.’, 89(9). Available at: https://doi.org/10.1136/jnnp-2017-316791.

Kurmann R et al. (2018) ‘Impact of Smoking on Clinical Outcome and Recanalization After Intravenous Thrombolysis for Stroke: Multicenter Cohort Study.’, Stroke, 49(5), pp. 1170–1175. Available at: https://doi.org/10.1161/strokeaha.117.017976.

Traenka C et al. (2018) ‘Endovascular therapy versus intravenous thrombolysis in cervical artery dissection ischemic stroke - Results from the SWISS registry.’, European stroke journal, 3(1), pp. 47–56. Available at: https://doi.org/10.1177/2396987317748545.

Gensicke H et al. (2018) ‘Intravenous thrombolysis and platelet count.’, Neurology, 90(8), pp. e690–e697. Available at: https://doi.org/10.1212/wnl.0000000000004982.

De Marchis, Gian Marco et al. (2018) ‘Serum neurofilament light chain in patients with acute cerebrovascular events’, European Journal of Neurology, 25(3), pp. 562–568. Available at: https://doi.org/10.1111/ene.13554.

Scheitz, Jan F. et al. (2018) ‘Cohort profile: Thrombolysis in Ischemic Stroke Patients (TRISP): a multicentre research collaboration’, BMJ Open, 8. Available at: https://doi.org/10.1136/bmjopen-2018-023265.

Scheitz JF et al. (2017) ‘Intracerebral Hemorrhage and Outcome After Thrombolysis in Stroke Patients Using Selective Serotonin-Reuptake Inhibitors.’, Stroke, 48(12), pp. 3239–3244. Available at: https://doi.org/10.1161/strokeaha.117.018377.

Traenka C et al. (2017) ‘Cervical artery dissection in patients ≥60 years: Often painless, few mechanical triggers.’, Neurology, 88(14), pp. 1313–1320. Available at: https://doi.org/10.1212/wnl.0000000000003788.

Spaander FH et al. (2017) ‘Sex Differences and Functional Outcome After Intravenous Thrombolysis.’, Stroke, 48(3), pp. 699–703. Available at: https://doi.org/10.1161/strokeaha.116.014739.

Gensicke H et al. (2017) ‘Prognostic significance of proteinuria in stroke patients treated with intravenous thrombolysis.’, European journal of neurology, 24(2), pp. 262–269. Available at: https://doi.org/10.1111/ene.13179.

Seiffge, David J. et al. (2017) ‘Intravenous Thrombolysis in Patients with Stroke Taking Rivaroxaban Using Drug Specific Plasma Levels: Experience with a Standard Operation Procedure in Clinical Practice’, Journal of Stroke, 19(3), pp. 347–355. Available at: https://doi.org/10.5853/jos.2017.00395.

Gensicke H et al. (2016) ‘Impact of body mass index on outcome in stroke patients treated with intravenous thrombolysis.’, European journal of neurology, 23(12), pp. 1705–1712. Available at: https://doi.org/10.1111/ene.13071.

Gensicke H et al. (2016) ‘Intravenous Thrombolysis in Patients Dependent on the Daily Help of Others Before Stroke.’, Stroke, 47(2), pp. 450–6. Available at: https://doi.org/10.1161/strokeaha.115.011674.

Simonetti BG et al. (2016) ‘Erratum to: Risk factors, aetiology and outcome of ischaemic stroke in young adults: the Swiss Young Stroke Study (SYSS).’, 263(1). Available at: https://doi.org/10.1007/s00415-015-7977-z.

Weil, Marie-Theres et al. (2016) ‘Loss of Myelin Basic Protein Function Triggers Myelin Breakdown in Models of Demyelinating Diseases’, Cell reports, 16(2), pp. 314–322. Available at: https://doi.org/10.1016/j.celrep.2016.06.008.

Zeis, Thomas, Enz, Lukas and Schaeren-Wiemers, Nicole (2016) ‘The immunomodulatory oligodendrocyte’, Brain Research, 1641, pp. 139–148. Available at: https://doi.org/10.1016/j.brainres.2015.09.021.

Goeggel Simonetti B et al. (2015) ‘Risk factors, aetiology and outcome of ischaemic stroke in young adults: the Swiss Young Stroke Study (SYSS).’, Journal of neurology, 262(9), pp. 2025–32. Available at: https://doi.org/10.1007/s00415-015-7805-5.

Gensicke H, Bonati LH and ICSS-MRI Substudy Investigators (2015) ‘Reply: Stent Type and Risk of Late Cerebral Events After Carotid Artery Stenting.’, 66(4). Available at: https://doi.org/10.1016/j.jacc.2015.05.042.

Kellert L. et al. (2015) ‘Anemia in young patients with ischaemic stroke’, European Journal of Neurology, 22(6), pp. 948–953. Available at: https://doi.org/10.1111/ene.12687.

Gensicke H et al. (2015) ‘New ischaemic brain lesions in cervical artery dissection stratified to antiplatelets or anticoagulants.’, European journal of neurology, 22(5), pp. 859–65, e61. Available at: https://doi.org/10.1111/ene.12682.

Bloch C et al. (2015) ‘Only a Touch of the Flu? The Simultaneous Manifestation of Acute Necrotizing Encephalopathy in Two Consanguineous Patients.’, Open forum infectious diseases, 2(2), p. ofv013. Available at: https://doi.org/10.1093/ofid/ofv013.

Gensicke H et al. (2015) ‘Ischemic brain lesions after carotid artery stenting increase future cerebrovascular risk.’, Journal of the American College of Cardiology, 65(6), pp. 521–9. Available at: https://doi.org/10.1016/j.jacc.2014.11.038.

Grond-Ginsbach C. et al. (2015) ‘Cervical Artery Dissection (CeAD) in physicians’, Cerebrovascular Diseases, 39(1), pp. 72–74. Available at: https://doi.org/10.1159/000369779.

Perriard, Guillaume et al. (2015) ‘Interleukin-22 is increased in multiple sclerosis patients and targets astrocytes’, Journal of Neuroinflammation, 12, p. 119. Available at: https://doi.org/10.1186/s12974-015-0335-3.

Gensicke H. (2014) ‘Erratum: IV thrombolysis and renal function (Neurology (2013) 81 (1780-1788))’, Neurology, 83(17), p. 1583. Available at: https://doi.org/10.1212/wnl.0000000000000972.

Lyrer PA et al. (2014) ‘Clinical import of Horner syndrome in internal carotid and vertebral artery dissection.’, Neurology. 11.04.2014, 82(18), pp. 1653–9. Available at: https://doi.org/10.1212/wnl.0000000000000381.

Drexler I et al. (2014) ‘Internal carotid artery dissection and asymmetrical facial flushing: the Harlequin sign.’, Stroke, 45(5), pp. e78–80. Available at: https://doi.org/10.1161/strokeaha.114.004830.

Scheitz JF et al. (2014) ‘Dose-related effects of statins on symptomatic intracerebral hemorrhage and outcome after thrombolysis for ischemic stroke.’, Stroke, 45(2), pp. 509–14. Available at: https://doi.org/10.1161/strokeaha.113.002751.

Seiffge, D J et al. (2014) ‘Simple variables predict miserable outcome after intravenous thrombolysis’, European journal of neurology, 21(2), pp. 185–91. Available at: https://doi.org/10.1111/ene.12254.

Strbian D et al. (2013) ‘Relationship between onset-to-door time and door-to-thrombolysis time: a pooled analysis of 10 dedicated stroke centers.’, Stroke, 44(10), pp. 2808–13. Available at: https://doi.org/10.1161/strokeaha.113.000995.

Strbian D et al. (2013) ‘Ultra-early intravenous stroke thrombolysis: do all patients benefit similarly?’, Stroke, 44(10), pp. 2913–6. Available at: https://doi.org/10.1161/strokeaha.111.000819.

Engelter ST et al. (2013) ‘Cervical artery dissection: trauma and other potential mechanical trigger events.’, Neurology. 01.05.2013, 80(21), pp. 1950–7. Available at: https://doi.org/10.1212/wnl.0b013e318293e2eb.

Zinkstok SM et al. (2013) ‘Safety of thrombolysis in stroke mimics: results from a multicenter cohort study.’, Stroke, 44(4), pp. 1080–4. Available at: https://doi.org/10.1161/strokeaha.111.000126.

Gensicke H et al. (2013) ‘Long-term outcome in stroke patients treated with IV thrombolysis.’, Neurology. 13.02.2013, 80(10), pp. 919–25. Available at: https://doi.org/10.1212/wnl.0b013e3182840c35.

Gensicke H and Fischer D (2013) ‘Response to Wakerley et al. letter: Surgery itself does not trigger Guillain-Barré syndrome.’, 20(3). Available at: https://doi.org/10.1111/ene.12064.

Corporaal, Sharissa H A et al. (2013) ‘Balance control in multiple sclerosis : correlations of trunk sway during stance and gait tests with disease severity’, Gait & posture, 37(1), pp. 55–60. Available at: https://doi.org/10.1016/j.gaitpost.2012.05.025.

De Marchis, G. M. et al. (2013) ‘Copeptin adds prognostic information after ischemic stroke: results from the CoRisk study’, Neurology, 80(14), pp. 1278–86. Available at: https://doi.org/10.1212/wnl.0b013e3182887944.

Gensicke, Henrik et al. (2013) ‘IV thrombolysis and renal function’, Neurology : journal of the American Academy of Neurology, 81(20), pp. 1780–8. Available at: https://doi.org/10.1212/01.wnl.0000435550.83200.9e.

Gensicke H et al. (2013) ‘Characteristics of ischemic brain lesions after stenting or endarterectomy for symptomatic carotid artery stenosis: results from the international carotid stenting study-magnetic resonance imaging substudy.’, Stroke, 44(1), pp. 80–6. Available at: https://doi.org/10.1161/strokeaha.112.673152.

Halliday A. et al. (2013) ‘Status update and interim results from the asymptomatic carotid surgery trial-2 (ACST-2)’, European Journal of Vascular and Endovascular Surgery, 46(5), pp. 510–518. Available at: https://doi.org/10.1016/j.ejvs.2013.07.020.

Nardi K et al. (2012) ‘Lipid profiles and outcome in patients treated by intravenous thrombolysis for cerebral ischemia.’, Neurology. 25.07.2012, 79(11), pp. 1101–8. Available at: https://doi.org/10.1212/wnl.0b013e3182608c82.

Gensicke H, Engelter S and Bonati L (2012) ‘[Endovascular treatment for carotid artery stenosis].’, Therapeutische Umschau. Revue therapeutique, 69(9), pp. 523–35. Available at: https://doi.org/10.1024/0040-5930/a000325.

Amort M et al. (2012) ‘Etiological classifications of transient ischemic attacks: subtype classification by TOAST, CCS and ASCO--a pilot study.’, Cerebrovascular diseases (Basel, Switzerland). 25.04.2012, 33(6), pp. 508–16. Available at: https://doi.org/10.1159/000337236.

Fanchamps, Malou H J et al. (2012) ‘Screening for balance disorders in mildly affected multiple sclerosis patients’, Journal of neurology, 259(7), pp. 1413–9. Available at: https://doi.org/10.1007/s00415-011-6366-5.

Gensicke, H et al. (2012) ‘Increased incidence of Guillain-Barré syndrome after surgery’, European journal of neurology, 19(9), pp. 1239–44. Available at: https://doi.org/10.1111/j.1468-1331.2012.03730.x.

Gensicke, H. et al. (2012) ‘Monoclonal Antibodies and Recombinant Immunoglobulins for the Treatment of Multiple Sclerosis’, CNS Drugs, 26(1), pp. 11–37. Available at: https://doi.org/10.2165/11596920-000000000-00000.

Thalmann R. et al. (2012) ‘Thrombolysis in stroke patients: Prognostic significance of prior statin treatment and cholesterol profile’, Schweizer Archiv fur Neurologie und Psychiatrie, 163, pp. 130–137. Available at: https://doi.org/10.4414/sanp.2012.02375.

Grossman, P et al. (2010) ‘MS quality of life, depression, and fatigue improve after mindfulness training: a randomized trial’, Neurology : journal of the American Academy of Neurology, 75(13), pp. 1141–9. Available at: https://doi.org/10.1212/wnl.0b013e3181f4d80d.